Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zippelius

Showing results (251-260 of 308) with videos related to

Pageof 31
Sort By:
Nature Medicine|June 13, 2018
A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockadeDaniela S Thommen, Viktor H Koelzer, Petra Herzig, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Nature Genetics|June 2, 2025
Phylogenetic inference reveals clonal heterogeneity in circulating tumor cell clustersDavid Gremmelspacher, Johannes Gawron, Barbara M Szczerba, et al.
Journal for Immunotherapy of Cancer|July 14, 2026
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunityNicole Oelgarth, Kea Martin, Fabian Junker, et al.
Cell Reports|November 14, 2024
Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunityAnna-Marie Pedde, Hyunu Kim, Sainitin Donakonda, et al.
Cell Reports. Medicine|March 25, 2021
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attackWeldy V Bonilla, Nicole Kirchhammer, Anna-Friederike Marx, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patientsDaniel E Speiser, Katrin Schwarz, Petra Baumgaertner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapyAbhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, et al.
Nature Immunology|October 6, 2020
Disturbed mitochondrial dynamics in CD8<sup>+</sup> TILs reinforce T cell exhaustionYi-Ru Yu, Hana Imrichova, Haiping Wang, et al.
Cell Reports|September 26, 2019
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor ResponsesAbhishek S Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, et al.
Pageof 31

Showing results (251-260 of 308) with videos related to

Sort By:
Pageof 31
Nature Medicine|June 13, 2018
A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockadeDaniela S Thommen, Viktor H Koelzer, Petra Herzig, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Nature Genetics|June 2, 2025
Phylogenetic inference reveals clonal heterogeneity in circulating tumor cell clustersDavid Gremmelspacher, Johannes Gawron, Barbara M Szczerba, et al.
Journal for Immunotherapy of Cancer|July 14, 2026
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunityNicole Oelgarth, Kea Martin, Fabian Junker, et al.
Cell Reports|November 14, 2024
Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunityAnna-Marie Pedde, Hyunu Kim, Sainitin Donakonda, et al.
Cell Reports. Medicine|March 25, 2021
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attackWeldy V Bonilla, Nicole Kirchhammer, Anna-Friederike Marx, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patientsDaniel E Speiser, Katrin Schwarz, Petra Baumgaertner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapyAbhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, et al.
Nature Immunology|October 6, 2020
Disturbed mitochondrial dynamics in CD8<sup>+</sup> TILs reinforce T cell exhaustionYi-Ru Yu, Hana Imrichova, Haiping Wang, et al.
Cell Reports|September 26, 2019
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor ResponsesAbhishek S Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, et al.
Pageof 31